Large scale analysis of OMICS data for drug-target finding in neurodegenerative diseases

Basic Information

Network

JPND

Website

https://neurodegenerationresearch.eu/initiatives/annual-calls-for-proposals/2023-research-call-on-large-scale-analysis-of-omics-data-for-drug-target-finding-in-neurodegenerative-diseases/

Aim of the joint call

Neurodegenerative diseases are debilitating and largely untreatable conditions that are strongly linked with age. Worldwide, there are estimated to be 50 million people with Alzheimer’s disease and related disorders. This figure is expected to double every 20 years as the population ages. The total direct and informal care costs of Alzheimer’s, Parkinson’s and related disorders are expected to surpass €350 billion per year across the European Union. Existing treatments for neurodegenerative diseases are limited and mainly address the symptoms rather than the cause or the progressive course. With this in mind, JPND has identified a pressing need for investment aimed at enabling research projects on large scale analysis of Omics data for drug-target finding in neurodegenerative diseases.

Type of joint call

Two Stages - Call with pre-proposals and full proposals submissions

Events

-                                                Launch date
+/01/2023
-                                                Deadline Pre-Proposal
+/03/2023 Submitted proposal: n/a
-                                                Deadline Full-Proposal
+/06/2023 Submitted proposal: n/a
-                                                Evaluation End Date
+                                                n/a
                                                Successful proposal: n/a
                                                Proposals funded: n/a

Is call co-funded?

Call follow up funding

n/a

Call reasons

n/a

Research fields

Health

Type of research

n/a

Target groups

n/a

Participating networks

n/a

Organisations Participating

Show on map

Country	Organisation
Austria	Austrian Research Promotion Agency (FFG)
Belgium	National Fund for Scientific Research (FNRS)
Canada	Canadian Institutes of Health Research (CIHR)
Czech Republic	Ministry of Education Youth and Sports (MEYS-MSMT)
France	National Research Agency (ANR)
Germany	Federal Ministry of Education and Research (BMBF)
Hungary	National Research, Development and Innovation Office (NKFIH)
Ireland	Health Research Board (HRB)
Israel	Ministry of Health (CSO-MOH)
Italy	Ministry of Health (MOH/MDS)
Luxembourg	National Fund for Research (FNR)
Netherlands	The Netherlands Organisation for Health Research and Development (ZonMw)
Poland	National Science Centre (NCN)
Slovakia	Ministry of Education, Science, Research and Sport of the Slovak Republic (MINEDU)
Spain	Institute of Health Carlos III (ISCIII)
Sweden	Swedish Research Council (VR/SRC)
Switzerland	Swiss National Science Foundation (SNSF/SNF)
Türkiye	The Scientific and Technological Research Council of Turkey (TUBITAK)

Funded Projects

Acronym	Title	No. partners
4DPD-Omics	Spatiotemporal transcriptome and proteome analysis of alpha-...	7
AD-PLCG2	Towards druggable targets in Alzheimer’s disease through cha...	5
ADPriOMICS	Prioritization of pathways linking aging and Alzheimer’s dis...	7
CCAD	Deciphering the Chemoproteomics and Chemo transcriptomics of...	7
MetaboAD	Metabolomics-Driven Biomarker Discovery of Alzheimer’s Disease	5
MyRIAD	(Micro)RNA and informatics approaches for diagnosis, prognos...	5
PRIONOMICS	Prioritizing diagnostics and therapeutics of human prion dis...	7
SMNuHoMICS	Unraveling the Role of SMN in Nucleolar Homeostasis and Pote...	3
SynOD	alpha-Synuclein OMICS to identify Drug-targets	6
WesternND	Targeting Western Diet-Induced Neurodegeneration	5
delCAA-HD	Delineating the role of HTT Cis-Variants in the pathogenesis...	5